Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc announced that David Blain, a Director of the company, purchased 84,053 ordinary shares at 11.75 pence each, increasing his stake to 0.08% of the issued ordinary shares. This transaction, disclosed under UK Market Abuse Regulation, highlights insider confidence in the company’s strategic direction and potential growth, possibly affecting investor sentiment positively.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company focused on developing products that modify the human microbiome to manage diseases and promote wellness. The company, founded in 2012, collaborates with international food and healthcare companies to integrate its microbiome modulators into various food and drink products. OptiBiotix also develops consumer supplements targeting obesity, cardiovascular health, and diabetes.
Average Trading Volume: 219,133
Technical Sentiment Signal: Sell
Current Market Cap: £11.1M
For an in-depth examination of OPTI stock, go to TipRanks’ Overview page.